secwatch.observer — SEC 8-K summary
======================================

Issuer:     ULTRALIFE CORP (ULBI)
CIK:        0000875657
Form:       8-K
Filed at:   2022-10-27T23:59:59+00:00
Accession:  0001437749-22-024877
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ultralife Q3 rev up 53% to $33.2M; net loss narrows to $0.2M but gross margin slides
--------------------------------------------------------------------------------

- Revenue $33.2M, up 53% YoY; net loss $0.2M ($0.01/share) vs loss $0.6M ($0.04) in Q3 2021.
- Government/defense sales doubled YoY; backlog reached $106.2M, up 153% from prior year.
- Gross margin fell to 20.2% from 23.5%, pressured by supply chain disruptions and cost inflation.
- Battery & Energy Products revenue $28.6M (+43%); organic growth 8.5% after excluding Excell contribution.
- Operating loss improved to $0.6M; adjusted EBITDA $1.3M (3.8% of sales) vs $0.3M (1.3%) a year ago.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/875657/000143774922024877/0001437749-22-024877-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/875657/000143774922024877/ulbi20221025_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-024877

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer